Insigneo Advisory Services’s AbbVie ABBV Stock Holding History

Insigneo Advisory Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$29.2M	Buy	115,953 +100,409	+646%	+$21.6M	1.09%	20
2026 Q1	$3.38M	Sell	15,544 -995	-6%	-$221K	0.24%	73
2025 Q4	$3.78M	Buy	16,539 +188	+1%	+$42.8K	0.27%	60
2025 Q3	$3.79M	Sell	16,351 -51	-0.3%	-$10.4K	0.27%	60
2025 Q2	$3.04M	Buy	16,402 +2,940	+22%	+$546K	0.26%	73
2025 Q1	$2.82M	Buy	13,462 +50	+0.4%	+$9.72K	0.29%	68
2024 Q4	$2.38M	Sell	13,412 -6,870	-34%	-$1.26M	0.25%	78
2024 Q3	$4.01M	Sell	20,282 -2,380	-11%	-$444K	0.4%	43
2024 Q2	$4.18M	Sell	22,662 -264	-1%	-$43.7K	0.47%	36
2024 Q1	$4.17M	Buy	22,926 +1,250	+6%	+$215K	0.5%	35
2023 Q4	$3.36M	Buy	21,676 +5,470	+34%	+$797K	0.47%	35
2023 Q3	$2.42M	Sell	16,206 -710	-4%	-$104K	0.49%	38
2023 Q2	$2.28M	Buy	16,916 +8,090	+92%	+$1.19M	0.44%	46
2023 Q1	$1.41M	Buy	8,826 +479	+6%	+$73.2K	0.45%	41
2022 Q4	$1.35M	Buy	+8,347	New	+$1.28M	0.51%	42

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Insigneo Advisory Services's ABBV Position: Q2 2026 in Review

Insigneo Advisory Services increased its AbbVie (ABBV) stake by 646% in Q2 2026, buying an estimated $21.6M and bringing the position to 115,953 shares worth $29.2M. The position accounts for 1.09% of the portfolio, ranked #20.

Insigneo Advisory Services first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,206 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Insigneo Advisory Services held 115,953 shares of AbbVie worth $29.2M as of Q2 2026.
Insigneo Advisory Services bought 100,409 AbbVie shares in Q2 2026, an estimated $21.6M.
AbbVie made up 1.09% of Insigneo Advisory Services's portfolio in Q2 2026, its #20 holding.
Insigneo Advisory Services first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
4,206 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Insigneo Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.